Acquisition and Long-term Observation of Patients With Severe Allergic Reactions

Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jan 14, 2022

Keywords

ClinConnect Summary

This clinical trial, called the Anaphylaxis Registry, is focused on understanding severe allergic reactions known as anaphylaxis. The goal is to collect information about what causes these reactions, what symptoms people experience, and how they are treated. By gathering this data in a consistent way, researchers hope to improve how anaphylaxis is diagnosed and managed in the long term, making it safer for those affected.

If you or a loved one has had an anaphylactic reaction in the past 12 months, you may be eligible to participate in this study. The trial is currently recruiting participants of all ages and genders. Those who join can expect to provide information about their experiences with anaphylaxis, which will help researchers gain insights into this serious condition. Your involvement could contribute to better care for others facing similar challenges in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Anaphylactic reaction within the past 12 months
• Exclusion Criteria:
• • -